Home › NDC Lookup › RxCUI directory › RxCUI 242166

Porfimer sodium 75 MG Injection — RxCUI 242166

RxNorm drug concept · Semantic clinical drug
RxCUI 242166 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI242166
Official namePorfimer sodium 75 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Porfimer sodium 75 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Porfimer sodium 75 MG Injection RxCUI 242166

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dihematoporphyrin ether 23066
    • Porfimer sodium 333848
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Photofrin 225244
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dihematoporphyrin ether Injection 1791252
    • Porfimer sodium Injection 2647552
    • Dihematoporphyrin ether Injectable Product 1151523
    • Porfimer sodium Injectable Product 2662806
    • Dihematoporphyrin ether Injection [Photofrin] 1791255
    • Porfimer sodium Injection [Photofrin] 2657539
    • Photofrin Injectable Product 1180642
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Porfimer sodium 75 MG SCDC · 1791251
  • Dihematoporphyrin ether Injection SCDF · 1791252
  • Porfimer sodium Injection SCDFP · 2647552
  • Dihematoporphyrin ether Injectable Product SCDG · 1151523
  • Porfimer sodium Injectable Product SCDGP · 2662806

Brand-Name Concepts

  • Porfimer sodium 75 MG Injection [Photofrin] SBD · 687066
  • Porfimer sodium 75 MG [Photofrin] SBDC · 1791254
  • Dihematoporphyrin ether Injection [Photofrin] SBDF · 1791255
  • Porfimer sodium Injection [Photofrin] SBDFP · 2657539
  • Photofrin Injectable Product SBDG · 1180642
  • Photofrin BN · 225244

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 242166 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76128-0155-75 1 VIAL in 1 BOX, UNIT-DOSE (76128-155-75) / 31.8 mL in 1 VI... Photofrin Pinnacle Biologics, Inc. 1995-12-27
Observed labelers: Pinnacle Biologics, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.